DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 153 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2018. The put-call ratio across all filers is 1.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $153,000 | -33.8% | 10,848 | -79.1% | 0.00% | – |
| Q4 2020 | $231,000 | +23.5% | 51,848 | +19.7% | 0.00% | – |
| Q3 2020 | $187,000 | -64.7% | 43,308 | -27.5% | 0.00% | -100.0% |
| Q2 2020 | $530,000 | +430.0% | 59,708 | +137.2% | 0.00% | – |
| Q2 2019 | $100,000 | -56.9% | 25,177 | -20.8% | 0.00% | – |
| Q1 2019 | $232,000 | -12.1% | 31,803 | +10.1% | 0.00% | – |
| Q4 2018 | $264,000 | -36.5% | 28,882 | -13.9% | 0.00% | -100.0% |
| Q3 2018 | $416,000 | -20.8% | 33,562 | -2.5% | 0.00% | 0.0% |
| Q2 2018 | $525,000 | +109.2% | 34,435 | +195.0% | 0.00% | 0.0% |
| Q3 2017 | $251,000 | +512.2% | 11,673 | +11.4% | 0.00% | – |
| Q4 2016 | $41,000 | -63.7% | 10,482 | -3.1% | 0.00% | – |
| Q3 2016 | $113,000 | -81.1% | 10,812 | -55.7% | 0.00% | -100.0% |
| Q3 2015 | $598,000 | +8.9% | 24,380 | +4.0% | 0.00% | 0.0% |
| Q2 2015 | $549,000 | -1.4% | 23,437 | -5.6% | 0.00% | 0.0% |
| Q1 2015 | $557,000 | – | 24,817 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 11,771,708 | $115,951,000 | 7.60% |
| Chicago Capital, LLC | 5,878,959 | $57,908,000 | 2.26% |
| PFM Health Sciences, LP | 2,990,770 | $29,459,000 | 0.92% |
| Avidity Partners Management LP | 3,400,000 | $33,490,000 | 0.90% |
| MIZUHO MARKETS AMERICAS LLC | 617,358 | $6,081,000 | 0.72% |
| Rhenman & Partners Asset Management AB | 750,000 | $7,388,000 | 0.50% |
| Jackson Creek Investment Advisors LLC | 115,333 | $1,136,000 | 0.42% |
| Rock Springs Capital Management LP | 1,679,921 | $16,547,000 | 0.33% |
| FEDERATED HERMES, INC. | 14,243,800 | $140,301,000 | 0.26% |
| JACKSON SQUARE CAPITAL, LLC | 80,400 | $792,000 | 0.25% |